Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: proposed study protocol for a prospective, randomized superiority trial

Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: proposed study protocol for a prospective, randomized superiority trial

Abstract Background Diabetes mellitus is associated with risk of sudden sensorineural hearing loss (SSNHL). Systemic and intratympanic corticosteroids are the two primary treatments for SSNHL in patients with diabetes mellitus. The benefit of intratympanic compared to systemic treatment is the reduc...

Full description

Bibliographic Details
Main Authors: Weiqiang Yang, Xiaoling Li, Jiatao Zhong, Xueshuang Mei, Hongyu Liu, Le Yang, Liming Lu, Hongyi Hu
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Trials
Subjects:
Sudden sensorineural hearing loss
Diabetes
Randomized controlled trial
Intratympanic methylprednisolone
Intravenous methylprednisolone
Online Access:https://doi.org/10.1186/s13063-020-4077-x

Internet

https://doi.org/10.1186/s13063-020-4077-x

Similar Items